- Home
- ROIV vs ERJ Comparison
ROIV vs ERJ Comparison
Compare ROIV & ERJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- ERJ
- Stock Information
- Founded
- ROIV 2014
- ERJ 1969
- Country
- ROIV United Kingdom
- ERJ Brazil
- Employees
- ROIV N/A
- ERJ N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- ERJ Aerospace
- Sector
- ROIV Health Care
- ERJ Industrials
- Exchange
- ROIV Nasdaq
- ERJ Nasdaq
- Market Cap
- ROIV 8.6B
- ERJ 10.5B
- IPO Year
- ROIV N/A
- ERJ 2000
- Fundamental
- Price
- ROIV $14.10
- ERJ $57.02
- Analyst Decision
- ROIV Strong Buy
- ERJ Buy
- Analyst Count
- ROIV 4
- ERJ 5
- Target Price
- ROIV $15.50
- ERJ $58.25
- AVG Volume (30 Days)
- ROIV 6.7M
- ERJ 1.4M
- Earning Date
- ROIV 11-11-2025
- ERJ 11-07-2025
- Dividend Yield
- ROIV N/A
- ERJ 0.09%
- EPS Growth
- ROIV N/A
- ERJ 11.89
- EPS
- ROIV N/A
- ERJ 0.53
- Revenue
- ROIV $23,233,000.00
- ERJ $7,305,193,434.00
- Revenue This Year
- ROIV N/A
- ERJ N/A
- Revenue Next Year
- ROIV $281.14
- ERJ $11.48
- P/E Ratio
- ROIV N/A
- ERJ $106.52
- Revenue Growth
- ROIV N/A
- ERJ 40.55
- 52 Week Low
- ROIV $8.73
- ERJ $32.26
- 52 Week High
- ROIV $14.48
- ERJ $62.09
- Technical
- Relative Strength Index (RSI)
- ROIV 74.33
- ERJ 48.30
- Support Level
- ROIV $13.81
- ERJ $56.76
- Resistance Level
- ROIV $14.48
- ERJ $62.09
- Average True Range (ATR)
- ROIV 0.42
- ERJ 1.45
- MACD
- ROIV 0.16
- ERJ -0.27
- Stochastic Oscillator
- ROIV 84.76
- ERJ 24.56
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About ERJ Embraer S.A.
Embraer SA based in Sao Paulo, Brazil, manufacturer of jets. Its focus is to achieve customer satisfaction with and services addressing the commercial airline, executive jets, and defense and security markets. It has developed a customer-centric technology-driven portfolio of commercial aviation products and services that allows it to build long-term relationships with clients in the commercial aviation, executive jets, and defense and security markets. It operates through the various segments namely Commercial Aviation, Defense and Security, Executive Aviation, Service and Support, and Other Segments. The company generates maximum revenue from the Commercial Aviation segment.